4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000903423-17-000632
10% owner bought 428,571 shares at $14.00 ($5,999,994)
- 10% owner acquired 1,425,435 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion | +244,147 | 244,147 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion | +246,272 | 490,419 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion | +328,992 | 819,411 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion | +606,024 | 1,425,435 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Purchase | +428,571 | $14.00 | $5,999,994 | 1,854,006 | I |
| Derivatives | |||||||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion · Junior preferred stock | −1,483,784 | 0 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion · Series A preferred stock | −982,906 | 0 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion · Series B preferred stock | −1,250,000 | 0 | I | ||
| GLAXOSMITHKLINE PLC 10% owner | 2017-11-06 | Conversion · Series C preferred stock | −3,683,045 | 0 | I | ||
| Open-market purchases · 428,571 sh · avg $14.00 · $5,999,994 | |||||||
Loading xslF345X03/glaxo-spero.xml…